ISSN: 2211-3428

Journal Guideline

Cellular Oncology Q1 Unclaimed

Springer Netherlands Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions. A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations. Focuses on translational researchAddresses the conversion of cell biology to clinical applications It has an SJR impact factor of 1,489.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Molecular Medicine (Q1) Oncology (Q1) Cancer Research (Q2)

Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,489

SJR Impact factor

58

H Index

147

Total Docs (Last Year)

252

Total Docs (3 years)

9711

Total Refs

1445

Total Cites (3 years)

250

Citable Docs (3 years)

5.11

Cites/Doc (2 years)

66.06

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways

A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells

The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer

TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation

Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis

DBD-F induces apoptosis in gastric cancer-derived cells through suppressing HIF2a expression

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer

Schedule-dependent cytotoxicity of sunitinib and TRAIL in human non-small cell lung cancer cells with or without EGFR and KRAS mutations

The role of caveolin-1 in tumors of the brain - functional and clinical implications

High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer

Differential effect of TGFbeta on the proteome of cancer associated fibroblasts and cancer epithelial cells in a co-culture approach - a short report

SHOW MORE ARTICLES

Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression

Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes

BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-beta/PI3K/AKT/mTOR signalling pathway

ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma

Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients

Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment

Establishment and genetic characterization of an immortal tumor cell line derived from intestinal-type sinonasal adenocarcinoma

Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN

Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study

Anti-tumor activity of the TGF-beta receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts

Low frequency of HER2 amplification and overexpression in early onset gastric cancer

Erratum to: ACP, volume 33, issues 1, 2, 3-4 and 5-6, 2010